Device Trial Radar · NCT00552812
Coarctation Of the Aorta Stent Trial
Last checked: Nov 20, 2026Latest source record: Mar 11, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
105
Actual
Start
Oct 2007
Primary completion
Dec 2012
Study completion Jul 2015
Sponsor
- Lead sponsor
- Richard E. RingelAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 2, 2007
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 8 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Cheatham Platinum bare metal stents are safe and effective in the treatment of native and recurrent aortic coarctation in selected children, adolescents and adults.
Conditions
- Coarctation of the Aorta
Interventions
Stent therapy of aortic coarctationDevice
Transcatheter delivery of a metallic stent to enlarge region of aortic narrowing caused by the coarctation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Difference Between Arm and Leg Systolic Blood Pressure From Baseline to 12 MonthsTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Children's Hospital Boston
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.